Skip to main content
Veterinary Medicines

Eurican Piro, liofilizado e solvente para suspensão injetável

Authorised
  • Babesia canis, soluble parasite antigen, Inactivated

Product identification

Medicine name:
Eurican Piro, liofilizado e solvente para suspensão injetável
Active substance:
  • Babesia canis, soluble parasite antigen, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Babesia canis, soluble parasite antigen, Inactivated
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AO
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Portugal Unipessoal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 347/90DGV
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 13/07/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."